1. Home
  2. SRDX vs EVN Comparison

SRDX vs EVN Comparison

Compare SRDX & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • EVN
  • Stock Information
  • Founded
  • SRDX 1979
  • EVN 1998
  • Country
  • SRDX United States
  • EVN United States
  • Employees
  • SRDX N/A
  • EVN N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • EVN Investment Bankers/Brokers/Service
  • Sector
  • SRDX Health Care
  • EVN Finance
  • Exchange
  • SRDX Nasdaq
  • EVN Nasdaq
  • Market Cap
  • SRDX 415.4M
  • EVN 410.0M
  • IPO Year
  • SRDX 1998
  • EVN N/A
  • Fundamental
  • Price
  • SRDX $35.41
  • EVN $10.58
  • Analyst Decision
  • SRDX Buy
  • EVN
  • Analyst Count
  • SRDX 2
  • EVN 0
  • Target Price
  • SRDX $43.00
  • EVN N/A
  • AVG Volume (30 Days)
  • SRDX 209.2K
  • EVN 101.2K
  • Earning Date
  • SRDX 08-12-2025
  • EVN 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • EVN 4.78%
  • EPS Growth
  • SRDX N/A
  • EVN N/A
  • EPS
  • SRDX N/A
  • EVN 0.34
  • Revenue
  • SRDX $121,575,000.00
  • EVN N/A
  • Revenue This Year
  • SRDX N/A
  • EVN N/A
  • Revenue Next Year
  • SRDX $3.19
  • EVN N/A
  • P/E Ratio
  • SRDX N/A
  • EVN $29.94
  • Revenue Growth
  • SRDX N/A
  • EVN N/A
  • 52 Week Low
  • SRDX $26.00
  • EVN $8.64
  • 52 Week High
  • SRDX $41.32
  • EVN $10.45
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 64.76
  • EVN 62.60
  • Support Level
  • SRDX $34.64
  • EVN $10.39
  • Resistance Level
  • SRDX $38.10
  • EVN $10.59
  • Average True Range (ATR)
  • SRDX 1.48
  • EVN 0.12
  • MACD
  • SRDX 0.20
  • EVN 0.01
  • Stochastic Oscillator
  • SRDX 65.50
  • EVN 67.92

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About EVN Eaton Vance Municipal Income Trust

Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.

Share on Social Networks: